Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2026-02-23 @ 6:27 AM
Study NCT ID:
NCT03125395
Status:
COMPLETED
Last Update Posted:
2020-08-07
First Post:
2017-04-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Rollover Safety Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-12
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-17
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-19
First Submit QC Date:
None
Study First Post Date:
2017-04-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-07-15
Results First Submit QC Date:
None
Results First Post Date:
2020-08-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-15
Last Update Post Date:
2020-08-07
Last Update Post Date Type:
ACTUAL